Latest Ceo Transitions News

PlaySide Studios reported a 25% revenue decline to $48.7 million for FY25, resulting in a $12.1 million net loss. The company is banking on new game launches and cost savings to reverse the downturn in FY26.

Mach7 Technologies Limited reported a 16% revenue increase to AUD 33.8 million for FY25, alongside a 22% reduction in net loss, driven by a strategic shift to subscription-based sales and disciplined cost management.

Kip McGrath Education Centres reported solid FY25 growth in revenue and EBITDA from continuing operations, marked by a strategic exit from the USA and a new share buy-back program.

Integral Diagnostics Limited (ASX – IDX) reported a robust FY25 performance, boosted by its transformative merger with Capitol Health Limited. The company posted strong revenue and profit growth, declared a 4.0 cent final dividend, and outlined strategic priorities including AI adoption and teleradiology expansion.

Tyro Payments reported modest transaction growth and a 10.6% rise in EBITDA for FY25, while preparing for a CEO change and expanding into new industry verticals.

Michael Hill International reported a steady FY25 with revenue holding firm at $643.7 million and a return to profitability despite ongoing retail challenges. The year saw strategic store closures, digital sales growth, and leadership changes, setting the stage for a reset under new CEO Jonathan Waecker.

Endeavour Group reported a slight revenue decline and a 16% drop in profit for FY25, alongside significant leadership changes including the appointment of a new CEO. The company is advancing its technology separation and sustainability initiatives while maintaining dividend payments.

Monash IVF Group reported steady FY25 financial results with revenue and EBITDA growth, while managing clinical incidents and a CEO transition. The company outlines cautious FY26 guidance amid industry headwinds.

Peet Limited reported a robust FY25 with a 60% surge in net profit after tax and declared a higher fully franked dividend, underpinned by strong sales and improved capital management. The company is also undertaking a strategic business review while navigating leadership transitions.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Saunders International reported a slight revenue dip and a sharp EBITDA decline in FY2025, offset by a transformative acquisition that dramatically expands its order book and pipeline.

Region Group delivered a robust FY25 with a $212.5 million statutory profit driven by property revaluations, steady distributions, and strong portfolio metrics. The REIT also advanced sustainability goals and announced CEO retirement plans, setting the stage for strategic continuity.